-3,9-11 HIV persists in a reservoir of latently infected CD4 + T cells in individuals treated with highly active antiretroviral therapy (HAART). Here we identify central memory (T CM ) and transitional memory (T TM ) CD4 + T cells as the major cellular reservoirs for HIV and find that viral persistence is ensured by two different mechanisms. HIV primarily persists in T CM cells in subjects showing reconstitution of the CD4 + compartment upon HAART. This reservoir is maintained through T cell survival and low-level antigen-driven proliferation and is slowly depleted with time. In contrast, proviral DNA is preferentially detected in T TM cells from aviremic individuals with low CD4 + counts and higher amounts of interleukin-7-mediated homeostatic proliferation, a mechanism that ensures the persistence of these cells. Our results suggest that viral eradication might be achieved through the combined use of strategic interventions targeting viral replication and, as in cancer, drugs that interfere with the self renewal and persistence of proliferating memory T cells.
Treatment of HIV infection has markedly reduced the death rate from AIDS and improved the quality of life of HIV-infected individuals 1 . However, complete eradication of HIV with antiretroviral drugs seems impossible, as the virus persists in cellular reservoirs 2, 3 . The major HIV reservoir is a small pool of latently infected resting memory CD4 + T cells carrying an integrated form of the viral genome 4, 5 that lacks the ability to produce viral proteins 6 . CD4 + T cell depletion is associated with a larger viral reservoir size 7 , whereas early initiation of HAART is often associated with a reduced size of the HIV reservoir 8 and the normalization of the CD4/CD8 ratio 9 . These observations suggest that CD4 + T cell depletion, which is directly associated with increased levels of CD4 + T cell proliferation 10, 11 , may drive the size of the HIV reservoir by as yet unidentified mechanisms.
Two distinct mechanisms could contribute to the persistence of this reservoir. First, low levels of viral replication could lead to de novo infection of memory CD4 + T cells, ensuring the continuous replenishment of the HIV reservoir 12, 13 . However, the absence of genetic evolution in viral reservoirs does not support this possibility [13] [14] [15] [16] [17] . Moreover, plasma viral RNA sequences under HAART diverge from cell-associated viral DNA, providing further evidence that de novo infection of cells is unlikely to be implicated in the persistence of the reservoir 18 . The intrinsic stability of latently infected CD4 + T cells constitutes an alternative explanation for the stability of the reservoir, as T CM cells survive for years [19] [20] [21] . Indeed, we have shown that prosurvival pathways are specifically triggered in T CM cells 21, 22 , indicating that T CM cells may encompass the long-lived HIV reservoir. The differentiation of T CM cells into T EM cells is observed after T cell receptor (TCR) triggering 23, 24 and, to a lesser extent, in response to homeostatic cytokines such as interleukin-7 (IL-7) and IL-15 (ref. 25) . The contribution of antigen-induced or homeostatic proliferation to the size and maintenance of the reservoir has yet to be defined. This is particularly relevant in the context of HAART, where high levels of immune activation, increased plasma concentrations of IL-7 and an increased percentage of cycling CD4 + T cells have been observed in individuals with low absolute CD4 + T cell counts 26 . Here we show the presence of two distinct HIV reservoirs: one in T CM cells, regulated by antigen-driven proliferation, and one in T TM cells, regulated by homeostatic proliferation.
RESULTS

HIV proviral DNA is detected in T CM and T TM cells
To identify the major molecular forms of HIV associated with its persistence, we measured levels of total DNA, integrated DNA and 2-LTR circles, which are labile intermediates in the virus life cycle, in CD4 + T cells from 14 successfully treated individuals, including four subjects from whom we obtained peripheral blood mononuclear cells (PBMCs) before and after initiation of HAART. The results indicated a rapid and profound drop in levels of 2-LTR circles upon initiation of HAART (Fig. 1a) , whereas HIV proviral DNA was more stable than and present in similar amounts to total HIV DNA after prolonged HAART (Fig. 1b) , confirming that the total HIV DNA found in CD4 + T cells after prolonged virus suppression largely represents integrated HIV genomes, as recently reported 27 . These results identify integrated viral DNA as the major and most stable molecular form of HIV in CD4 + T cells from successfully treated subjects.
To determine whether the stability of integrated viral DNA can be attributed to the persistence of specific memory CD4 + T cell compartments, we sorted CD4 + T cell subsets from 17 aviremic subjects (Supplementary Table 1 ) on the basis of surface expression of CD45RA, CC chemokine receptor-7 (CCR7) and CD27 and performed highly sensitive quantification of integrated HIV proviral DNA on the sorted subsets. On the basis of CD45RA and CCR7 expression, we identified various CD4 + subsets, including naive (T N ), central memory (T CM ) and terminally differentiated (T TD ) cells ( Supplementary Fig. 1a ). CD27 expression allowed us to distinguish effector memory (T EM ) cells from the transitional memory CD4 + T cell subset (T TM cells); the latter cells show functional and transcriptional characteristics that are intermediate between those of T CM cells and T EM cells 21 .
We determined the percentage of each cellular subset within the pool of CD4 + T cells from 31 aviremic individuals (Fig. 1c) . The frequency of cells within each subset harboring HIV proviral DNA ranged from 0 to 10.2 Â 10 3 copies of HIV provirus per 1 Â 10 6 cells of a given subset ( Fig. 1d and Supplementary Fig. 1b) . Our results clearly indicate that the HIV reservoir constitutes cells harboring a memory phenotype (mean contributions of T CM cells and T TM and T EM cells of 51.7% and 46.6%, respectively), whereas T N cells and T TD cells marginally contribute to the pool of cells harboring HIV proviral DNA (mean contributions of 1.9% and 0.3%, respectively, Fig. 1e) . Overall, the contributions of T CM cells and T TM cells to the HIV reservoir were higher than that of T EM cells (mean contributions of 51.7%, 34.3% and 13.9%, respectively). To confirm that CD4 + T cells harbor replication-competent virus, we sorted cells from each subset of four aviremic subjects and measured viral production after co-culture and stimulation with allogeneic dendritic cells and phytohemagglutininactivated CD4 + T cells from HIV-negative donors ( Supplementary  Fig. 2 ). These results showed that CD4 + T cells subsets harboring HIV proviral DNA are able to produce infectious virus after stimulation.
We also measured the frequency of cells harboring HIV proviral DNA in lymph nodes and gut biopsies from successfully treated individuals ( Supplementary Fig. 3a-f) . We found that lymph nodes were enriched (fold enrichment of 2.4) for memory CD4 + T cells as compared to blood, but the frequencies of memory CD4 + T cells harboring proviral DNA were comparable in both compartments T CM  T TM  T EM  T TD   T N  T CM  T TM+EM T TM T EM  T TD   100   80   60   40 (means of 516 copies and 603 copies of HIV integrated DNA in 1 Â 10 6 memory CD4 + T cells from PBMCs and lymph node mononuclear cells, respectively). We did the same quantifications in PBMCs and matched gut biopsies from eight subjects on HAART; the results showed that the frequencies of cells harboring HIV proviral DNA are similar and highly correlated between these two compartments (Supplementary Fig. 3f) . Together, these experiments show that T CM , T TM and T EM cells contribute to various degrees to the HIV reservoir and can produce infectious viral particles upon activation. Moreover, experiments with PBMCs of individuals on HAART, aimed at quantifying proviral DNA, did indeed reflect the contribution of the lymphoid tissue environment to the HIV reservoir.
Absolute CD4 + count identifies the HIV reservoir Our results also showed that the relative contributions of T CM and T TM cells to the pool of HIV-infected cells are highly variable from one subject to another (Fig. 1e) . We observed that CD4/CD8 ratios 41, high nadir CD4 + count and initiation of HAART within the first year of HIV infection are strongly associated with an HIV reservoir of limited size (P o 0.0001, P ¼ 0.0005 and P o 0.0001, respectively; Fig. 2a-c) . As CD4 + T cell depletion was also associated with an increased HIV reservoir size (P ¼ 0.03, Fig. 2d ), we examined whether absolute CD4 + counts affect the reservoir localization in T CM and T TM cells. We found that T CM cells were underrepresented in subjects with low CD4 + counts, suggesting that T CM cells are selectively depleted or differentiated into T TM cells in these subjects (P ¼ 0.02, Fig. 2e) . Moreover, the frequency of infected T TM cells was higher in subjects with low CD4 + counts, whereas T CM cells were preferentially infected in subjects with high absolute CD4 + counts (P o 0.0001, Fig. 2f ). As T CM cells were overrepresented and preferentially infected in individuals with high CD4 + counts, they constituted the major reservoir for HIV in those subjects (P ¼ 0.004, Fig. 2g) . Conversely, the HIV reservoir was mainly localized in T TM cells in individuals with low CD4 + counts (P ¼ 0.006).
Immune activation identifies the HIV reservoir Depletion of CD4 + T cells is associated with high levels of immune activation and increased proliferation of CD4 + T cells 10, 11, 26 . As we found that the absolute CD4 + count determines the size and the localization of the HIV reservoir, we examined the impact of the residual immune activation on these parameters. Absolute CD4 + counts were negatively correlated with the expression of the immune activation and proliferation marker Ki67 in CD4 + T cells (P ¼ 0.007, Fig. 3a) . Notably, high frequencies of Ki67 + CD4 + T cells were associated with a larger size of the viral reservoir (P ¼ 0.01, Fig. 3b ), suggesting that T cell proliferation might provide a mechanism for the maintenance of the HIV reservoir. Moreover, we found that the levels of cellular proliferation could predict not only the size but also the localization of the HIV reservoir, as high levels of Ki67 protein expression were correlated with preferential infection of T TM cells (P ¼ 0.008, Fig. 3c ) and with a higher contribution of this subset to the HIV reservoir (P ¼ 0.0006, Fig. 3d ). Conversely, T CM cells were the main reservoir in individuals with limited levels of cellular proliferation (P ¼ 0.002; Fig. 3d ).
Together, these results indicate that low absolute CD4 + counts are associated with high levels of cellular proliferation and an increased size of an HIV reservoir mainly harbored by T TM cells. Conversely, we observed a viral reservoir of limited size mainly harbored by T CM cells in individuals with high absolute CD4 + counts and limited proliferation of CD4 + T cells.
T CM and T TM CD4 + T cells define distinct HIV reservoirs
We next characterized the phenotypes of T CM cells and T TM cells to determine whether their contribution to the HIV reservoir is a function of their proliferative status. T TM cells included higher frequencies of Ki67 + and PD-1 + cells than T CM cells but lower frequencies than T EM cells (Fig. 3e) . Moreover, and irrespective of the phenotype of the CD4 + subset, the HIV reservoir was mainly composed of cells endowed with limited proliferation indexes (Ki67, P o 0.0001 and PD-1, P ¼ 0.0002), confirming the quiescent nonactivated state of cells that constitute the HIV reservoir in HAART-treated subjects 2 (Fig. 3f) Fig. 3g ). Quantification of HIV proviral DNA in each fraction showed that PD-1 hi cells were enriched for HIV proviral DNA when compared to the corresponding PD-1 lo fractions (P ¼ 0.016), confirming that proliferating T CM and T TM cells constitute a privileged cellular reservoir for HIV (Fig. 3h) . These results indicate that HIV preferentially persists in T CM and T TM cells that proliferate at low levels.
The T TM cell reservoir is fueled by proliferating T CM cells
We amplified Env sequences from proviral DNA obtained from T CM cells and T TM cells of ten HAART-treated subjects and performed phylogenetic analyses to assess the interdependence of each cellular reservoir by comparing HIV sequences obtained from both cellular reservoirs (Fig. 4a) . With the exception of three clones obtained from one subject, all viruses (n ¼ 427) were predicted to use CCR5; hence, co-receptor usage could not allow us to evidence the interdependence of the T CM and T TM reservoirs. However, sequences obtained from T CM cells and T TM cells of individuals that were good responders to HAART (see subject D as an example, CD4 + Ki67 + ¼ 1.4%) did not cluster together, indicating that in those subjects these reservoirs are genetically independent (Fig. 4a) . In contrast, in aviremic subjects characterized by higher levels of CD4 + T cell proliferation (for example, subject A, CD4 + Ki67 + ¼ 3.5%), viral quasispecies were shared by T CM cells and T TM cells, as shown by the unique cluster of variants found in the neighbor-joining tree (Fig. 4a) . When performed in ten subjects, the phylogenetic analysis confirmed that increased turnover of T TM cells is associated with a reduced HIV genetic distance measured between the two compartments (P ¼ 0.0005, Fig. 4b ), a consequence of the residual immune activation and cell proliferation leading to the differentiation of T CM cells into T TM cells 10, 11 .
Cell proliferation ensures HIV reservoir stability
We determined the impact of cellular proliferation on the genetic diversity of proviral DNA within both cellular reservoirs. We did not find any association between the genetic diversity of the T CM reservoir and levels of T CM cell proliferation (Fig. 4c) , indicating that T CM cells harboring archived proviral DNA constitute a stable reservoir with minimal proliferation levels, in agreement with their enhanced survival 21 . In contrast, proliferation of T TM cells was associated with a reduced HIV diversity in this subset (P ¼ 0.001, Fig. 4c ). This result suggested a mechanism by which HIV-infected T TM cells maintain the size and the lack of HIV genetic diversity of the viral reservoir by continuous self-renewal through the proliferation of a small number of cells. To verify this hypothesis, we performed a longitudinal analysis in five aviremic subjects from whom we obtained viral sequences at two time points separated by at least 14 months (Supplementary Table 2 and Supplementary Fig. 4 ). We aligned sequences obtained from T CM cells and T TM cells at these two time points and drew phylogenetic trees reflecting the evolution of viral sequences ( Fig. 5a and Supplementary Fig. 5 ). To measure the genetic evolution of the HIV reservoir, we quantified the divergence as the average genetic distance between sequences from the two time points within each T cell subset (Fig. 5b) . Our results indicated that high proliferation levels in T TM cells are associated with a limited genetic evolution of the reservoir over time, in agreement with a mechanism by which persistence of this reservoir is ensured by a small number of HIV-infected proliferating CD4 + T cells (subject A, Fig. 5a ,b).
To our surprise, in subjects with low frequencies of Ki67 + cells, sequences obtained from the two time points did not cluster together (subject E, Fig. 5a,b) . The apparent evolution of HIV sequences in individuals with high CD4 + T cell counts probably reflects the sampling of different archived sequences rather than a genetic evolution of the proviral populations. These sequences may be present at variable frequencies as a consequence of the proliferation and death of distinct T cell clones in subjects who are still endowed with a functional CD4 + compartment [31] [32] [33] .
HIV reservoir is maintained by IL-7-mediated proliferation CD4 + T cell depletion is directly correlated with high levels of plasma [34] [35] [36] , a cytokine responsible for the survival and homeostatic proliferation of CD4 + T cells 25, 37, 38 . We observed higher amounts of IL-7 in the plasma of individuals with a high frequency of proliferating cells and limited evolution of the viral reservoir over time (Fig. 5b) . We then assessed the role of this cytokine in the maintenance of the size of the reservoir. We determined the frequency of CD4 + T cells harboring proviral DNA in eight aviremic HAART-treated subjects at two different time points with at least 14 months between independent measurements (Fig. 5c) . The size of the viral reservoir decreased very slowly with time in the eight aviremic subjects tested. We analyzed our data by using a previously described regression model 39 , and we found a mean half-life of this reservoir of 39.5 months, indicating that an average of 65.7 years of treatment would be necessary to eradicate 1 Â 10 6 infected cells. Of note, we observed a significant negative correlation between this decrease and the percentage of proliferating T TM cells (P ¼ 0.007, Fig. 5d ). Moreover, we observed that plasma IL-7 concentrations inversely correlated with the decrease of the reservoir size over time (P ¼ 0.037, Fig. 5e ).
Altogether, these results indicate that IL-7 is responsible for the persistence of latently HIV-infected CD4 + T cells by promoting homeostatic proliferation of memory CD4 + T cells, resulting in the quantitative and qualitative stability of the HIV reservoir.
Cellular proliferation influences the HIV reservoir
We performed in vitro experiments to evaluate the relative impact of antigen-induced and homeostatic proliferation on the maintenance of the HIV reservoir. We stimulated CD4 + T cells from two virally suppressed subjects through TCR triggering (CD3 and CD28) or incubate them with IL-7 in the presence of zidovudine and ritonavir to avoid possible de novo infection of cells with HIV. We observed that TCR triggering induced modifications in the distribution of CD4 + T cell subset and was accompanied by high levels of proliferation (Fig. 6a,b) . In contrast, IL-7 at 1 ng ml À1 and 10 ng ml À1 was able to induce proliferation of CD4 + T cells with limited impact on the distribution of the various naive and memory T cell subsets, confirming the homeostatic nature of the proliferation induced by this cytokine. Analysis of HIV sequences after IL-7 treatment indicated that this cytokine induced the proliferation of CD4 + T cells without modifying the diversity of the viral reservoir, as indicated by the absence of a significant difference in the genetic diversity of the proviral populations at baseline and after 8 d of culture (Fig. 6c) . In contrast, CD4 + T cells treated with CD3 and CD28 showed a significant reduction in the diversity of the proviral population (subjects 1 and 2, P ¼ 0.0002 and P o 0.0001, respectively). Of note, we used the same number of positive PCR reactions for cloning of proviral quasispecies under each experimental condition (n ¼ 7), indicating that the decrease in viral genetic diversity is unlikely to be attributable exclusively to cell death. Thus, the decrease in the viral genetic diversity observed after TCR triggering is most probably attributable to the specific expansion of a small number of HIVinfected memory CD4 + T cell clones, which are undergoing substantial proliferation in our cultures at day 8, as indicated by increased frequencies of Ki67 + cells (Fig. 6b) . This observation supports our findings in vivo showing that TCR-induced proliferation is responsible for the specific expansion of a restricted number of CD4 + T cell clones harboring a limited set of divergent HIV sequences (Fig. 5a) . Thus, these results indicate that IL-7 can mediate the survival of HIVinfected cells through homeostatic proliferation, thereby ensuring the persistence of a genetically stable HIV reservoir, whereas antigeninduced proliferation leads to the genetic evolution of the proviral population through the preferential proliferation and survival of a restricted number of CD4 + T cell clones.
DISCUSSION
We have identified two viral reservoirs within memory CD4 + T cell subsets of virally suppressed subjects. The T CM reservoir is the major long-lasting reservoir in immune responders to HAART. As T CM cells are characterized by their extremely low degree of cellular proliferation, and, because of their intrinsic capacity to survive for decades 20, 21 , these cells provide a long-lasting cellular reservoir for HIV. In immune responders to HAART with normal CD4 + counts, the size of the HIV reservoir decreases very slowly with time, indicating that this cellular reservoir could be partially depleted through the use of intensive antiviral strategies for prolonged periods of time. The second reservoir is harbored by T TM cells and is the main reservoir in individuals with low CD4 + counts, the majority of whom are characterized by persistent immune activation. Our results clearly show that this reservoir persists by homeostatic proliferation of infected T TM cells, ensuring the stability of this viral reservoir in its size and its genetic variability.
As the size of this T TM reservoir is reduced in individuals who have been treated early in infection, our findings confirm the importance of early therapeutic intervention, as it limits the size of this proliferating HIV reservoir 8 . Several studies have clearly shown the continuous production of virions during HAART 13, 40, 41 ; a recent analysis of longitudinal plasma samples suggests that this low-level, persistent viremia seems to arise from at least two cellular compartments, one in which viral production decays over time and a second that remains stable for at least 7 years 42 . Our identification of T CM cells and T TM cells as two major reservoirs that are characterized by differing decay rates in HAARTtreated individuals supports these findings. Our observations also provide the first evidence, to our knowledge, for the validity of the mathematical model proposed recently, in which bystander proliferation of HIV-infected CD4 + T cells can ensure HIV reservoir persistence without any demonstrable evidence for viral production 43 .
The impact of viral production on the replenishment of the HIV reservoir is still controversial 17, 18, [44] [45] [46] . A recent study concluded that persistence of the HIV reservoir is unlikely to result from ongoing viral replication, as sequences from the predominant plasma clones are different from those found in the proviral reservoir 18 . Moreover, genetic analysis of rebounding viruses after treatment interruptions argues against persistence of ongoing low-level replication in individuals on suppressive HAART 47 . Accordingly, our findings suggest a limited role for viral replication in the persistence of the reservoir. First, the nonstochastic distribution of HIV-infected cells among T cell subsets that are permissive to HIV infection suggests that de novo infection of CD4 + T cells does not occur. Second, HAART-treated individuals with high levels of immune activation, in whom ongoing replication is most likely to occur, do not show any evidence of genetic evolution in their proviral populations. Altogether, these observations strongly suggest that ongoing viral replication is unlikely to be responsible for the persistence of HIV-infected cells and strengthen the role of cell proliferation as a major mechanism to ensure HIV persistence. IL-7 has been shown to induce the proliferation and survival of memory CD4 + T cells 25 . We found that CD4 + T cell depletion is accompanied by increased amounts of IL-7, which provides a potential mechanism by which latently infected CD4 + T cells could proliferate in response to this cytokine, as measured by Ki67 expression. Our results are in line with a recent study indicating that CD4 + T cell proliferation in HIV-infected individuals (as assessed by BrdU incorporation) is driven by IL-7 as a homeostatic response to CD4 + T cell depletion 48 . However, our Ki67 measurements may have overestimated the frequency of dividing cells, as Ki67 + cells may not represent true in vivo proliferation in HIV-infected individuals, particularly in untreated subjects 49, 50 . These results and our observations suggest that a quantitatively stable pool of memory CD4 + T cells that include cells with integrated HIV DNA is maintained through continuous proliferation and apoptosis at low levels in HAARTtreated individuals with low CD4 + counts. Our longitudinal analysis shows that the stability of the HIV reservoir size and the conservation of viral sequences over time are associated with IL-7 concentrations in plasma. We observed here that IL-7 is able to induce homeostatic proliferation of CD4 + T cells in vitro, thereby ensuring the persistence of HIV proviral sequences. These observations show a role for IL-7 in the maintenance of latently infected CD4 + T cells through cytokineinduced homeostatic proliferation and survival.
Our results indicate that HIV persists in two reservoirs that are maintained by distinct mechanisms. Individuals who have started treatment early in infection carry a viral reservoir of limited size that is harbored mainly by T CM cells, which have the capacity to survive for long periods of time 21, 22 . Although these cells that harbor archived proviral DNA are highly stable, the reservoir may decrease at a very slow rate as a consequence of the ability of these cells to mount antigen-induced responses, leading to the elimination of a fraction of infected cells through CTL killing, cytopathic effect and apoptosis during the contraction phase. The HIV reservoir is mainly retrieved in T TM cells in subjects with increased frequencies of proliferating CD4 + T cells because HAART treatment was initiated at a later stage of the disease. This subset of CD4 + T cells continuously proliferates at low levels, leading to the persistence of a genetically stable HIV reservoir through IL-7-induced mitosis of T TM cells. These results suggest that therapeutic strategies relying solely upon antiretroviral molecules will never reach the objective of viral eradication.
Finally, our results indicate that HIV proviral DNA is harbored by cells that express immune activation and proliferation markers such as PD-1 and Ki67. New therapies should target pathways downstream of homeostatic proliferation including inhibitors of the IL-7 pathway or pathways associated with self-renewal and 'stem cell-ness' , such as those developed for the treatment of leukemias and cancers 51 . Indeed, by limiting immune activation and affecting long-lived infected CD4 + T cells by targeting IL-7-dependent proliferation and the self-renewal of memory T cells in association with HAART, eradication of virus in aviremic individuals could become a more realistic endeavor.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
Accession codes. Sequences for Env genes have been deposited in GenBank with accession numbers EU700514 to EU700943.
Note: Supplementary information is available on the Nature Medicine website.
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Isolation of cellular subsets and flow cytometry. We purified total CD4 + T cells by cell sorting after staining with FITC-labeled antibody to CD3 (555339) and allophycocyanin (APC)-labeled antibody to CD4 (340443). To isolate CD4 + subsets, we labeled PBMCs with FITC-labeled antibody to CD3 (555339), APC-labeled antibody to CD4 (340443), APC-Cy7-labeled antibody to CD45RA (624072), phycoerythrin (PE)-Cy7-labeled antibody to CCR7 (557648) and PE-labeled antibody to CD27 (555441). Alternatively, we used PerCP-Cy5.5-labeled antibody to CD4 (341654) and APC-labeled antibody to PD-1 (17-9969-73) to isolate T CM and T TM cells expressing or not expressing the PD-1 marker. We separated T cell subsets by FACSAria (BD Biosciences) to very high purity (498.0%).
For phenotypic analysis, we stained PBMCs with Pacific Blue-labeled antibody to CD3 (558117), Alexa 700-labeled antibody to CD4 (557922), APC-Cy7-labeled antibody to CD45RA (624072), PE-Cy7-labeled antibody to CCR7 (557648), PE-labeled antibody to CD27 (555441), APC-labeled antibody to CD25 (555434) and FITC-labeled antibody to CD71(347513). Alternatively, we used APC-labeled antibody to PD-1 (17-9969-73) to the surface cocktail and FITC-labeled antibody to Ki67 (556026) for intracellular staining. We purchased all antibodies from BD Biosciences except for APC-labeled antibody to PD-1 (eBioscience). We performed analyses on a LSRII (BD Bioscience) as previously described 52 .
HIV DNA quantification. We digested sorted cells as described previously 53 and used the lysates directly for amplification. We used a modified nested Alu PCR to quantify both integrated HIV DNA and CD3 gene copy numbers. As a standard curve for both quantifications, we amplified serial dilutions of ACH2 cells (US National Institute of Allergy and Infectious Diseases Reagent Program) ranging from 3 Â 10 5 to 3 cells at the same time as the experimental samples. We amplified integrated HIV sequences 54 and the CD3 gene 53 for 12 cycles in triplicate wells. We diluted the PCR products and determined HIV and CD3 copy numbers in separate second amplification reactions on the Light Cycler instrument (Roche Diagnostics). We determined HIV and CD3 copy numbers by using appropriate primers and probes 53, 54 . We carried out amplification reactions in Jumpstart Mix (Sigma) with 2 U of Taq Polymerase (Invitrogen), 1.25 mM primers and 0.2 mM fluorescent probes. We used similar methods to quantify total HIV DNA and 2-LTR circles, with the appropriate primers and probes 54 . For 2-LTR circle quantifications, we used serial dilutions of a plasmid harboring single copies of the CD3 gene and 2-LTR junction as a standard curve.
Coculture assays. We cultured sorted CD4 + T cell subsets from aviremic subjects with activated CD4 + T cells and dendritic cells from uninfected donors for their capacity to amplify viral production. We differentiated dendritic cells from monocytes in the presence of 1,500 U ml À1 granulocyte-macrophage colony-stimulating factor and 10 ng ml À1 IL-4 (R&D Systems) for 4 d. We stimulated purified CD4 + T cells from uninfected donors with 1 mg ml À1 phytohemagglutinin (Sigma) and 10 ng ml À1 IL-2 (R&D Systems) for 2 d. We cultured 0.5 Â 10 6 cells from sorted CD4 + T cell subsets with 0.1 Â 10 6 dendritic cells and 0.5 Â 10 6 uninfected CD4 + T cells. We collected half of the medium every 3 d and replaced it with fresh medium supplemented with IL-2. After 24 d of culture, we monitored HIV replication by p24 ELISA in supernatants.
Env gene amplification. We performed Env gene amplifications, cloning, sequencing and phylogenetic analyses as described previously 55 . We obtained 10-15 independent PCRs from each sample and sequenced 11-16 clones. To exclude the possibility of PCR resampling, we performed a single genome amplification assay in some samples and found similar results. In addition, the calculation of genetic divergence after excluding genetically close sequences obtained from the same cloning reaction gave similar results. All sequences have been submitted to GenBank.
Co-receptor usage prediction. We aligned translated gp120 sequences and did co-receptor usage predictions with the support vector machine analysis tool geno2pheno[co-receptor] version 1.0 (ref. 56 ) with a false positive rate of 0.05 for CXCR4 detection.
